These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7637658)

  • 21. ACE inhibitors for hypertension--again.
    Black P; Wrapson C
    N Z Med J; 2001 Apr; 114(1130):194. PubMed ID: 11396672
    [No Abstract]   [Full Text] [Related]  

  • 22. Moexipril in the treatment of mild to moderate essential hypertension: comparison with sustained-release verapamil.
    Abernethy DR; Fox AA; Stimpel M
    J Clin Pharmacol; 1995 Aug; 35(8):794-9. PubMed ID: 8522636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
    MMW Fortschr Med; 2000 Jan; 142(1-2):54-5. PubMed ID: 11291163
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of ischemic complications. ACE inhibitor helps in endothelial crisis].
    MMW Fortschr Med; 1999 Oct; 141(43):58-9. PubMed ID: 10912130
    [No Abstract]   [Full Text] [Related]  

  • 25. ACE inhibitors in the elderly.
    Posvar EL; Sedman AJ
    Angiology; 1991 May; 42(5):387-96. PubMed ID: 2035890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.
    Stimpel M; Koch B; Weber MA
    Maturitas; 1998 Sep; 30(1):69-77. PubMed ID: 9819786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women.
    Koch B; Oparil S; Stimpel M
    J Hum Hypertens; 1999 May; 13(5):337-42. PubMed ID: 10376852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension.
    Weir MR
    J Hum Hypertens; 1994 Sep; 8(9):725-30. PubMed ID: 7807504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
    Fortschr Med Monogr; 1993; 68():1-23. PubMed ID: 7728496
    [No Abstract]   [Full Text] [Related]  

  • 32. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACE inhibitors for hypertension.
    Lawrie MM
    N Z Med J; 2001 Feb; 114(1126):75-6. PubMed ID: 11280436
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for site-specific absorption of a novel ACE inhibitor.
    Grass GM; Morehead WT
    Pharm Res; 1989 Sep; 6(9):759-65. PubMed ID: 2554270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biohumoral and hemodynamic effects of angiotensin-converting enzyme inhibition in the hypertensive patient].
    Marchegiano R; Raponi M; Lamenza F; Crispino MR; Morrone G; Trimarco C; Lembo G
    Boll Soc Ital Biol Sper; 1988 Jul; 64(7):613-20. PubMed ID: 3228505
    [No Abstract]   [Full Text] [Related]  

  • 37. Using ACE inhibitors appropriately.
    Bicket DP
    Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide.
    Hutt V; Michaelis K; Verbesselt R; De Schepper PJ; Salomon P; Bonn R; Cawello W; Angehrn JC
    Eur J Clin Pharmacol; 1996; 51(3-4):339-44. PubMed ID: 9010710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological and clinical profile of moexipril: a concise review.
    Chrysant SG; Chrysant GS
    J Clin Pharmacol; 2004 Aug; 44(8):827-36. PubMed ID: 15286086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].
    Ostroumova OD; Paukov SV; Frolova LI
    Kardiologiia; 2006; 46(11):92-8. PubMed ID: 17159885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.